Global HIV Rapid Test Kits Market Outlook Report 2023-2028: Burgeoning Opportunities with the New Paradigm of Digital Support In HIV Self-Testing & Raise of Next-Generation HIV Test Technology
The global HIV rapid test kits market is projected to grow from $1,437.98 million in 2022 to $1,687.7 million by 2028, at a CAGR of 2.70%.
Increased awareness and government policies promoting HIV self-testing are key drivers. Despite the growth, challenges include incidences of false negatives and limited accessibility. Major players like Trinity Biotech and OraSure Technologies are expanding their product offerings, including next-generation kits. Collaboration with organizations like UNAIDS enhances market opportunities, especially in regions with high infection rates, such as Africa and Eastern Europe.
- Projected market growth from $1,437.98 million in 2022 to $1,687.7 million by 2028.
- Government support for HIV self-testing bolsters market growth.
- Advancements in next-generation HIV test technologies improve accuracy.
- Incidences of false negatives may deter user confidence.
- Limited accessibility and awareness of self-testing kits in some regions.
The global HIV rapid test kits market is expected to be valued at
In the
Human Immunodeficiency Virus (HIV) is a viral infection that attacks the body's immune system and does not have effective care treatment across the world. It leads to acquired immunodeficiency syndrome (AIDS). Globally, more than 38.4 million people are living with HIV infection, among which
HIV is one of the leading causes of death in the world. The Joint United Nations Programme on HIV/AIDS and WHO are two major health organizations working towards increasing awareness among people about HIV, HIV infection, and associated preventive measures.
These two organizations aim to reduce around
MARKET TRENDS & OPPORTUNITIES
Raise of Next-Generation HIV Test Technology
The rise of fourth-generation rapid test kits has become more popular in recent years. This technology is more accurate and reliable for screening the acute HIV presence in the sample. The 4th generation HIV test easily detects HIV in lesser time and more accurately than other generation technologies.
Such factors allow individuals to get a cure sooner and potentially prevent the spread of infection to others. One of the leading HIV rapid test kit market players, OraSure technologies, got approval for a home test kit known as "OraQuick In-Home HIV Test," which gives results in 20 to 40 minutes.
Increasing HIV Self-Testing Associated Government Policies
The UNAID and WHO are working together towards HIV prevention. Several strategic implementations are implemented worldwide to increase HIV self-testing (HIVST) and to understand the actual burden of HIV/AIDS globally.
Eastern and
New Paradigm of Digital Support In HIV Self-Testing
The COVID-19 pandemic led to several service disruptions in the supply of HIV diagnoses and treatments, which led to falling short of the UNAIDS 2030 target. However, the COVID-19 pandemic accelerated the application of digital tools in health services. The incorporation of digital tools gave a new paradigm in HIV care management.
The application of digital tools in HIV management is increasing that expected to fuel the HIV rapid test kits market. According to
Increasing Targeted Patient Population
Around 15,000,000 people acquired HIV in 2020. In 2022, more than 38 million people were expected to live with HIV. This further results in increasing HIV preventive measures, which include increasing the number of people undergoing HIV tests through self-test kits.
In high-infection regions such as
Increasing Awareness about HIV Self-Testing
Most countries are making significant progress in reducing the HIV burden with UNAIDS and WHO. Globally, around
Further, the increasing prevalence of HIV, the awareness among HIV-infected and non-infected people in developed and developing countries is increasing rapidly. In developed countries, HIV infection awareness increased through various government and health authorities' programs working as support to improve knowledge about HIV self-testing solutions.
The increasing access to HIV rapid test kits through health authorities and vendor activities and the acceptance of self-testing kits for HIV management are increasing simultaneously, fueling the HIV rapid test kits market growth.
GEOGRAPHICAL ANALYSIS
The Europe HIV rapid test kits market was valued at
VENDOR LANDSCAPE
The global HIV rapid test kits market has many global, regional, and domestic players that offer a comprehensive product portfolio of HIV rapid test kits. Some global market players have acquired high industry penetration with a broader distribution network and business strategies. Also, some companies collaborate with WHO and UNAIDS to increase the increasing rate of HIV self-testing by supporting HIV rapid test kits.
In 2022, WHO partnered with the
Key Metrics
Report Attribute | Details |
No. of Pages | 266 |
Forecast Period | 2022 - 2028 |
Estimated Market Value (USD) in 2022 | |
Forecasted Market Value (USD) by 2028 | |
Compound Annual Growth Rate | 2.7 % |
Regions Covered | Global |
Market Dynamics
Market Opportunities & Trends
- Introduction of Next Generation Hiv Rapid Test Kits
- Increase in Hiv Self-Testing by Government Bodies
- Digital Support for Hiv Self-Testing
Market Growth Enablers
- Increasing Hiv Patient Population
- Increased Resources Availability and Funding for Hiv Management
- Increased Awareness of Hiv Self-Testing
Market Restraints
- Increasing Incidences of False Negatives
- Limitations & Challenges Associated with Hiv Testing
- Low Accessiblity & Lack of Awareness for Hivst
Key Company Profiles
Abbott - Bio-Rad Laboratories
- BIOMERIEUX
- Chembio Diagnostics
- OraSure Technologies
Other Prominent Vendors
- Atomo Diagnostics
- AccuBioTech
- bioLytical Laboratories
- Biosynex
- Cupid Limited
- DIALAB
- HUMAN
- INTEC
J. Mitra & Co- Meril Life Sciences
MP Biomedicals - Medsource Ozone Biomedicals
- Nanjing Synthgene Medical Technology
- Premier Medical
- SD Biosensor
- KHB (Shanghai Kehua Bio-Engineering co., Ltd.)
- Turklab A.S.
Trinity Biotech - Wantai BioPharma
- Wondfo
For more information about this report visit https://www.researchandmarkets.com/r/v4vxhn-rapid-test?w=5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
SOURCE
FAQ
What is the expected growth of the TRIB HIV rapid test kits market by 2028?
What is driving the growth in the HIV rapid test kits market?
What challenges does the HIV rapid test kits market face?
How is Trinity Biotech involved in the HIV rapid test kits market?